Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 

Biopharma

The biopharma business develops, produces and markets prescription drugs for the therapeutic areas of Neurodegenerative Diseases, Oncology, Fertility, Endocrinology, CardioMetabolic Care and General Medicine.

Neurodegenerative diseases

Our goal is to offer people living with neurodegenerative diseases, such as multiple sclerosis, therapies that contribute significantly to the quality of life and meet patients’ needs.

Oncology

In oncology, we are focusing on therapeutic options that systematically target the tumor. The key is finding the right combination. This refers both to the targets of a therapy in the disease process and to the combination possibilities with standard therapies such as radiation or chemotherapy.

Fertility

For fertility treatment, we offer hormones for every stage of the reproductive cycle – from follicular development to early pregnancy.

Endocrinology

We are committed to the treatment and research of growth hormone deficiency, the rare disorder phenylketonuria (PKU) and other metabolic disorders.

CardioMetabolic Care

We offer a comprehensive range of therapeutic options for cardiovascular diseases, diabetes and thyroid diseases, thus making a significant contribution to effective treatment of often complex symptoms.

 

Biopharma

Our biopharma business is pursuing activities in selected indications for highly specialized therapeutic areas mainly treated by specialists. The portfolio includes leading biopharmaceutical drugs that benefit patients who suffer from colorectal cancer, head and neck tumors or multiple sclerosis. In addition, we offer therapies to treat infertility, growth disorders, cardiovascular diseases, diabetes and thyroid diseases
Research and development are focused on the fields of oncology, immuno-oncology, neurodegenerative diseases, fertility, endocrinology and biosimilars.
Biopharma: Key products by therapeutic area
Therapeutic Area Key Products
Oncology
  • Erbitux® (solid tumors)
Neurodegenerative Diseases
Fertility
Endocrinology
CardioMetabolic Care
  • Glucophage® franchise (type 2 diabetes)
  • Concor® franchise (cardiovascular diseases)
  • Euthyrox® (thyroid diseases)

More in M – The Explorer Magazine:

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

BIOPHARMA

www.emdserono.com

CLINICAL TRIALS

Clinical Trials
For information on clinical trials currently being conducted in the framework of our development projects, please click here.